Toward a 3D model of human brain development for studying gene/environment interactions

Stem Cell Research and Therapy

Volumn 4, Issue SUPPL.1, 2013, Pages

  Hogberg, Helena T ^a,b   Bressler, Joseph ^a   Christian, Kimberly M ^c   Harris, Georgina ^a   Makri, Georgia ^c   O'Driscoll, Cliona ^a   Pamies, David ^a   Smirnova, Lena ^a   Wen, Zhexing ^c   Hartung, Thomas ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CADMIUM CHLORIDE; CARBARIL; CHLORPYRIFOS; LAMOTRIGINE; LEAD CHLORIDE; LINDANE; MANEB; TRICHLOROETHYLENE; VALPROIC ACID; XENOBIOTIC AGENT;

BIOLOGICAL MODEL; BRAIN CELL CULTURE; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; DENDRITIC CELL; EPIGENETICS; EXPOSURE; FEASIBILITY STUDY; GENOTYPE ENVIRONMENT INTERACTION; GLIA CELL; HUMAN; IN VITRO STUDY; NERVE CELL; NERVE FIBER MEMBRANE; NEUROTOXICITY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYNAPTOGENESIS; THREE DIMENSIONAL MODEL;

ANIMALS; BRAIN; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; NEURAL STEM CELLS; NEURONS; XENOBIOTICS;

EID: 84891357438     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt365     Document Type: Review

References (39)

1. Guidance on Good Cell Culture Practice. A report of the Second ECVAM task force on good cell culture practice. Coecke S, Balls M, Bowe G, Davis J, Gstraunthaler G, Hartung T, Hay R, Merten OW, Price A, Schechtman L, Stacey G, Stokes W, Altern Lab Anim 2005 33 261 287 16180980 (Pubitemid 40964979)
2. Developmental neurotoxicity of industrial chemicals. Grandjean P, Landrigan PJ, Lancet 2006 368 2167 2178 10.1016/S0140-6736(06)69665-7 17174709 (Pubitemid 44894541)
3. National Center on Birth Defects and Developmental Disabilities. http://www.cdc.gov/ncbddd/index.html
4. Test No. 426: developmental neurotoxicity study.OECD Guidelines for the Testing of Chemicals/Section 4: Health Effects OECD 2007 http://www.oecd- ilibrary.org/environment/test-no-426-developmental-neurotoxicity-study- 9789264067394-en
5. US Environmental Protection Agency, Health Effects Guidelines OPPTS 870.6300 US EPA 1998 http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT- 2009-0156-0042
6. Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation. Tsuji R, Crofton KM, Congeni Anom (Kyoto) 2012 52 122 128 10.1111/j.1741-4520.2012.00374.x
7. Nanostructured superhydrophobic substrates trigger the development of 3D neuronal networks. Limongi T, Cesca F, Gentile F, Marotta R, Ruffilli R, Barberis A, Dal Maschio M, Petrini EM, Santoriello S, Benfenati F, Di Fabrizio E, Small 2013 9 402 412 10.1002/smll.201201377 23027505
8. Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. Eskes C, Juillerat-Jeanneret L, Leuba G, Honegger P, Monnet-Tschudi F, J Neurosci Res 2003 71 583 590 10.1002/jnr.10508 12548715 (Pubitemid 36163341)
9. A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. van Vliet E, Morath S, Eskes C, Linge J, Rappsilber J, Honegger P, Hartung T, Coecke S, Neurotoxicology 2008 29 1 12 10.1016/j.neuro.2007.09.007 18023877
10. Electrophysiological recording of re-aggregating brain cell cultures on multi-electrode arrays to detect acute neurotoxic effects. van Vliet E, Stoppini L, Balestrino M, Eskes C, Griesinger C, Sobanski T, Whelan M, Hartung T, Coecke S, Neurotoxicology 2007 28 1136 1146 10.1016/j.neuro.2007.06.004 17692379 (Pubitemid 350026589)
11. Ochratoxin A at nanomolar concentration perturbs the homeostasis of neural stem cells in highly differentiated but not in immature three-dimensional brain cell cultures. Zurich MG, Honegger P, Toxicol Lett 2011 205 203 208 10.1016/j.toxlet.2011.06.007 21703336
12. Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos. Zurich MG, Honegger P, Schilter B, Costa LG, Monnet-Tschudi F, Toxicol Appl Pharmacol 2004 201 97 104 10.1016/j.taap.2004.05.003 15541749 (Pubitemid 39487157)
13. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, Hareng L, Hartung T, Knaut H, Honegger P, Jacobs M, Lein P, Li A, Mundy W, Owen D, Schneider S, Silbergeld E, Reum T, Trnovec T, Monnet-Tschudi F, Bal-Price A, Environ Health Perspect 2007 115 924 931 10.1289/ehp.9427 17589601 (Pubitemid 46902248)
14. Meeting report: alternatives for developmental neurotoxicity testing. Lein P, Locke P, Goldberg A, Environ Health Perspect 2007 115 764 768 10.1289/ehp.9841 17520065 (Pubitemid 46785047)
15. In vitro and other alternative approaches to developmental neurotoxicity testing (DNT). Lein P, Silbergeld E, Locke P, Goldberg AM, Environ Toxicol Pharmacol 2005 19 735 744 10.1016/j.etap.2004.12.035 21783550
16. Challenge and Opportunity on the Critical Path to New Medical Products. http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/ CriticalPathOpportunitiesReports/ucm077262.htm
17. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA, Nat Biotechnol 2001 19 1129 1133 10.1038/nbt1201-1129 11731781 (Pubitemid 33115698)
18. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Moors M, Rockel TD, Abel J, Cline JE, Gassmann K, Schreiber T, Schuwald J, Weinmann N, Fritsche E, Environ Health Perspect 2009 117 1131 1138 10.1289/ehp.0800207 19654924
19. Hazard assessment of methylmercury toxicity to neuronal induction in embryogenesis using human embryonic stem cells. Stummann TC, Hareng L, Bremer S, Toxicology 2009 257 117 126 10.1016/j.tox.2008.12.018 19150642
20. Human cell-based micro electrode array platform for studying neurotoxicity. Yla-Outinen L, Heikkila J, Skottman H, Suuronen R, Aanismaa R, Narkilahti S, Front Neuroeng 2010 3
21. A human stem cell-based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system. Buzanska L, Sypecka J, Nerini-Molteni S, Compagnoni A, Hogberg HT, del Torchio R, Domanska-Janik K, Zimmer J, Coecke S, Stem Cells 2009 27 2591 2601 10.1002/stem.179 19609937
22. An efficient method for generation of neural-like cells from adult human bone marrow-derived mesenchymal stem cells. Alexanian AR, Regen Med 2010 5 891 900 10.2217/rme.10.67 21082889
23. In vitro differentiation of size-sieved stem cells into electrically active neural cells. Hung SC, Cheng H, Pan CY, Tsai MJ, Kao LS, Ma HL, Stem Cells 2002 20 522 529 10.1634/stemcells.20-6-522 12456960 (Pubitemid 35463065)
24. Long-term expansion of adult human brain subventricular zone precursors. Ayuso-Sacido A, Roy NS, Schwartz TH, Greenfield JP, Boockvar JA, Neurosurgery 2008 62 223 229 discussion 229-231 10.1227/01.NEU.0000311081.50648.4C 18300911
25. Differentiation of spinal motor neurons from pluripotent human stem cells. Hu BY, Zhang SC, Nat Protoc 2009 4 1295 1304 10.1038/nprot.2009.127 19696748
26. Growth factors regulate the survival and fate of cells derived from human neurospheres. Caldwell MA, He X, Wilkie N, Pollack S, Marshall G, Wafford KA, Svendsen CN, Nat Biotechnol 2001 19 475 479 10.1038/88158 11329020 (Pubitemid 32428293)
27. Embryonic stem-derived versus somatic neural stem cells: a comparative analysis of their developmental potential and molecular phenotype. Colombo E, Giannelli SG, Galli R, Tagliafico E, Foroni C, Tenedini E, Ferrari S, Corte G, Vescovi A, Cossu G, Broccoli V, Stem Cells 2006 24 825 834 10.1634/stemcells. 2005-0313 16339994 (Pubitemid 44464715)
28. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem cells and development. Emdad L, D'Souza SL, Kothari HP, Qadeer ZA, Germano IM, Stem Cells Dev 2011 21 404 410 21631388
29. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Chiang CH, Su Y, Wen Z, Yoritomo N, Ross CA, Margolis RL, Song H, Ming GL, Mol Psychiatry 2011 16 358 360 10.1038/mp.2011.13 21339753
30. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. Yuan SH, Martin J, Elia J, Flippin J, Paramban RI, Hefferan MP, Vidal JG, Mu Y, Killian RL, Israel MA, Emre N, Marsala S, Marsala M, Gage FH, Goldstein LS, Carson CT, PloS One 2011 6 17540 10.1371/journal.pone.0017540 21407814
31. Specification of neuronal and glial subtypes from human pluripotent stem cells. Liu H, Zhang SC, Cell Mol Life Sci 2011 68 3995 4008 10.1007/s00018-011- 0770-y 21786144
32. Milestones of directed differentiation of mouse and human embryonic stem cells into telencephalic neurons based on neural development in vivo. Nat R, Dechant G, Stem Cells Dev 2011 20 947 958 10.1089/scd.2010.0417 21166522
33. Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines. Wu H, Xu J, Pang ZP, Ge W, Kim KJ, Blanchi B, Chen C, Sudhof TC, Sun YE, Proc Natl Acad Sci USA 2007 104 13821 13826 10.1073/pnas.0706199104 17693548 (Pubitemid 350003404)
34. Aggregating neural cell cultures. Honegger PaM-T, F, Protocols for Neural Cell Cultures Totowa, NJ: Humana Press, Fedoroff S, 1 2001 199 218
35. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Hogberg HT, Kinsner-Ovaskainen A, Coecke S, Hartung T, Bal-Price AK, Toxicol Sci 2010 113 95 115 10.1093/toxsci/kfp175 19651682
36. Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. Hogberg HT, Kinsner-Ovaskainen A, Hartung T, Coecke S, Bal-Price AK, Toxicol Appl Pharmacol 2009 235 268 286 10.1016/j.taap.2008.12.014 19146868
37. Genomic instability and aging. Studies in centenarians (successful aging) and in patients with Down's syndrome (accelerated aging). Franceschi C, Monti D, Scarfi MR, Zeni O, Temperani P, Emilia G, Sansoni P, Lioi MB, Troiano L, Agnesini C, et al. Ann N Y Acad Sci 1992 663 4 16 10.1111/j.1749-6632.1992. tb38643.x 1282788 (Pubitemid 23090518)
38. Systemic oxidative stress in classic Rett syndrome. De Felice C, Ciccoli L, Leoncini S, Signorini C, Rossi M, Vannuccini L, Guazzi G, Latini G, Comporti M, Valacchi G, Hayek J, Free Radic Biol Med 2009 47 440 448 10.1016/j. freeradbiomed.2009.05.016 19464363
39. Genotype and cognitive phenotype of patients with tuberous sclerosis complex. van Eeghen AM, Black ME, Pulsifer MB, Kwiatkowski DJ, Thiele EA, Eur J Hum Genet 2012 20 510 515 10.1038/ejhg.2011.241 22189265